Veru wraps COVID trial early
To view this email as a web page, click here

Today's Rundown

Featured Story

FDA's Califf on accelerated approval: 'In God, we trust, everyone else must bring good evidence'

In an exclusive interview with Fierce Biotech, FDA Commissioner Robert Califf says the agency needs to do a better job of getting post-market data as it looks to fortify trust in the accelerated approval program. His comments came hours before the Centers for Medicare and Medicaid Services stuck with its coverage decision for Biogen's treatment for Alzheimer's.

read more

Top Stories

AACR: BioNTech showcases post-Comirnaty future with early cancer vaccine efficacy data

BioNTech’s post-Comirnaty future is emerging, with early phase 1/2 data from a solid tumor CAR-T cell therapy showing evidence of efficacy and a safety profile deemed manageable by the famed German biotech.

read more

Early wrap up for Veru's COVID trial spurs doubling of share price, race to regulators

Veru is quitting while it's ahead, closing up shop early on a phase 3 trial for a COVID-19 treatment in the sickest patients after initial data found that it reduced deaths by more than 50%. 

read more

AACR: C4's multiple myeloma data prompts dosing switch, giving patients a longer treatment reprieve

C4 Therapeutics has learned a lot from just five melanoma patients reporting out from the first cohort in a phase 1 trial for its lead candidate, a IKZF1/3 degrader called CFT7455. In data to be presented at the AACR meeting in New Orleans on April 12, C4 will showcase the early efficacy signals.

read more

AACR: Blueprint wants to make resistance to AstraZeneca's Tagrisso futile in lung cancer

About seven out of 10 patients with EGFR-mutated lung cancer progress after taking AstraZeneca’s Tagrisso, and a third of those patients see their cancer spread to the brain. Blueprint wants to change that.

read more

AACR: Exuma aims to be first to the clinic with under-the-skin cancer CAR cell therapy without complex manufacturing

Existing CAR-T therapies for blood cancers require painstaking preparation. Exuma Biotech believes its rapidly manufactured cell therapy can save patients precious time and obviate the need for preconditioning.

read more

AACR: Senti Bio fine-tunes cytokines to boost CAR-NK cell therapy for solid cancers

Senti Bio is perhaps best known for logic-gated gene circuits to control the therapeutic activity of cell and gene therapies. But CEO Tim Lu, M.D., Ph.D., has early data showing the biotech's CAR-NK platform has more tricks up its sleeve.

read more

Pfizer signals big M&A with new CFO Denton, the money manager behind the CVS-Aetna megamerger

Pfizer has signed on a new chief financial officer whose dealmaking experience could prove invaluable for the New York pharma as it looks to deploy its COVID-19 vaccine and drug windfall.

read more

Oxford University VR spinout demonstrates significant psychotherapy benefits in Lancet study

GameChangeVR automates psychotherapy, guiding users with a virtual coach. Significant benefits were obtained after six sessions, according to the study.

read more

Stryker lays off 88 workers, plowing ahead with plan to close Florida facility and eliminate 495 jobs

The next wave in a yearslong program of rolling layoffs at a Stryker facility in Florida is scheduled to take place at the end of May, the company said in a recent filing with the state.

read more

Moderna recalls vaccine batch after foreign substance found in CDMO-made vial—again

The specter of particulates has forced another recall—this time on Moderna’s massively successful COVID-19 vaccine Spikevax—and the latest pull isn’t contract manufacturer Rovi’s first brush with contamination, either.

read more

Resources

eBook: 5 Rules to Enhance Wound Care & Dermatology Clinical Trials

Net Health, experts in wound care and dermatology clinical trials, have a new eBook: 5 Rules to Enhance Clinical Trials in 2022, find out how to recruit the right participants, connect patients and researchers with technology, manage costs and more.

Infographic: United Cargo: Providing Comprehensive Solutions For the Most Critical Shipments

The United Cargo team has made a commitment to pharmaceutical and medical partners that we are equipped to support their vaccine transportation needs safely and effectively across our expansive global and domestic network. The safety and security of these commodities is our priority, and we are proud to be a trusted partner in these efforts. Download infographic now.

Research: Get Access to AdisInsight A Year In Review

The journey of drug development in 2021 delivered to your inbox: top 10 AdisInsight drug profiles viewed, new drug profiles released, overview of drug launches, key deals, research trends in 2021 and much more (free of charge).

Whitepaper: Oncology Market Outlook: Key Trends to Watch

What’s in store for the oncology market in 2022 and beyond? This paper looks at 5 trends driving the market.

Whitepaper: Uncovering the hidden value of quality in chemical supply

Learn how to position quality as a central component within your raw material sourcing strategies for the chemicals used throughout your workflows. Download the free whitepaper from Thermo Fisher Scientific.

Whitepaper: Autologous CAR T-Cell Manufacturing: Semiautomatic, Closed, Modular Workflow

Learn how to navigate the top manufacturing challenges and achieve a seamless transition from discovery to clinical manufacturing across the CAR T-cell therapy workflow.

eBook: EMEA Regulatory Roadblocks around Decentralized Trials

Learn about ways to break down regulatory roadblocks and get closer to 100% clarity on regulatory positions to advance decentralized clinical trials in research.

Whitepaper: Lipid-Based Drug Delivery System to Bring Poorly Soluble Drugs to Market

How can Lipid-Based Drug Delivery System help bring poorly soluble drugs to market?

Whitepaper: Versatility of Softgel Technology - Encapsulation of a Volatile Compound

Learn more about how the versatility of Softgel Technology helped a customer with a volatile compound.

Whitepaper: The Most Suitable Dosage Form Technologies for the Oral Delivery of Lipid-Based Formulations

What is the most suitable dosage form technology for the Oral Delivery of Lipid-Based Formulations?

Webinar: The Faster Path From Pre-Filled Syringe to Auto-Injector

Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar.

Whitepaper: Formulation Strategies When Transitioning From Vial to PFS

Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care.

Events